Close Menu
Home › Food Allergy Dx Firm AllerGenis, Luminex Ink Test Development Deal

Food Allergy Dx Firm AllerGenis, Luminex Ink Test Development Deal

Jan 16, 2019
|
staff reporter

NEW YORK (360Dx) – Food allergy diagnostic developer AllerGenis today announced a non-exclusive deal with Luminex for use of that company's xMAP technology to develop, market, and sell a precision food allergy diagnostic assay.

Financial and other terms of the deal were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

What's Popular?

In Immunoassays

  1. Roche's Cobas Pro Integrated Solutions Cleared for Marketing in US

  2. Machine Learning Can be Used to Better ID Low-Value Tests Commonly Used in Hospitals, Study Says

  3. 'Substantial Growth' Led This Lab to Replace its Testing Systems With Next-Generation Platforms

    Premium

  4. BioMérieux, Siemens Healthineers, Roche Diagnostics, Others Get FDA Clearances in August

  5. At-Home STI Testing Focus of Newly Standalone Firm Antelope Dx

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.